Like a middle school teacher repeatedly reminding students that a big paper is due, the US FDA continues to prompt drug sponsors to submit a mandatory one-time report on marketed products.
As part of the 2017 FDA Reauthorization Act, sponsors must submit a one-time update of the marketing status for all...